Year |
Citation |
Score |
2024 |
Padaga SG, Ch S, Paul M, Wable BD, Ghosh B, Biswas S. Chitosan oligosaccharide/pluronic F127 micelles exhibiting anti-biofilm effect to treat bacterial keratitis. Carbohydrate Polymers. 330: 121818. PMID 38368100 DOI: 10.1016/j.carbpol.2024.121818 |
0.494 |
|
2024 |
Ch S, Mishra P, Padaga SG, Ghosh B, Roy S, Biswas S. 3D-Printed Inherently Antibacterial Contact Lens-like Patches Carrying Antimicrobial Peptide Payload for Treating Bacterial Keratitis. Macromolecular Bioscience. e2300418. PMID 38258356 DOI: 10.1002/mabi.202300418 |
0.495 |
|
2023 |
Paul M, Ghosh B, Biswas S. Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer. International Journal of Biological Macromolecules. 128281. PMID 37992920 DOI: 10.1016/j.ijbiomac.2023.128281 |
0.575 |
|
2023 |
Hegde AR, Paul M, Kumbham S, Arup Roy A, Ahmad SF, Parekh H, Biswas S, Mutalik S. Ameliorative anticancer effect of dendrimeric peptide modified liposomes of letrozole: In vitro and in vivo performance evaluations. International Journal of Pharmaceutics. 123582. PMID 37940082 DOI: 10.1016/j.ijpharm.2023.123582 |
0.303 |
|
2023 |
Ghosh A, Himaja A, Biswas S, Kulkarni O, Ghosh B. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer. Molecular Pharmaceutics. PMID 37899551 DOI: 10.1021/acs.molpharmaceut.3c00610 |
0.534 |
|
2023 |
Pulya S, Himaja A, Paul M, Adhikari N, Banerjee S, Routholla G, Biswas S, Jha T, Ghosh B. Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. PMID 37660352 DOI: 10.1021/acs.jmedchem.3c00614 |
0.516 |
|
2023 |
Itoo AM, Paul M, Ghosh B, Biswas S. Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Biomaterials Advances. 153: 213550. PMID 37437383 DOI: 10.1016/j.bioadv.2023.213550 |
0.578 |
|
2023 |
Jain R, Paul M, Padaga SG, Dubey SK, Biswas S, Singhvi G. Dual-Drug-Loaded Topical Delivery of Photodynamically Active Lipid-Based Formulation for Combination Therapy of Cutaneous Melanoma. Molecular Pharmaceutics. PMID 37262335 DOI: 10.1021/acs.molpharmaceut.3c00280 |
0.343 |
|
2023 |
Rajaraman S, Balakrishnan R, Deshmukh D, Ganorkar A, Biswas S, Pulya S, Ghosh B. HDAC8 as an emerging target in drug discovery with special emphasis on medicinal chemistry. Future Medicinal Chemistry. PMID 37227732 DOI: 10.4155/fmc-2023-0054 |
0.494 |
|
2023 |
Ch S, Padaga SG, Ghosh B, Roy S, Biswas S. Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis. Carbohydrate Polymers. 312: 120822. PMID 37059521 DOI: 10.1016/j.carbpol.2023.120822 |
0.438 |
|
2023 |
Swetha KL, Paul M, Maravajjala KS, Kumbham S, Biswas S, Roy A. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle. Journal of Controlled Release : Official Journal of the Controlled Release Society. 356: 93-114. PMID 36841286 DOI: 10.1016/j.jconrel.2023.02.023 |
0.323 |
|
2022 |
Dinda B, Das B, Biswas S, Sharma H, Armstrong C, Yedlapudi D, Antonio T, Reith M, Dutta AK. Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein. Bioorganic & Medicinal Chemistry. 78: 117131. PMID 36571976 DOI: 10.1016/j.bmc.2022.117131 |
0.475 |
|
2022 |
Itoo AM, Paul M, Padaga SG, Ghosh B, Biswas S. Nanotherapeutic Intervention in Photodynamic Therapy for Cancer. Acs Omega. 7: 45882-45909. PMID 36570217 DOI: 10.1021/acsomega.2c05852 |
0.491 |
|
2022 |
Paul M, Itoo AM, Ghosh B, Biswas S. Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma. Journal of Photochemistry and Photobiology. B, Biology. 238: 112627. PMID 36525775 DOI: 10.1016/j.jphotobiol.2022.112627 |
0.513 |
|
2022 |
Paul M, Itoo AM, Ghosh B, Biswas S. Current trends in the use of human serum albumin for drug delivery in cancer. Expert Opinion On Drug Delivery. 1-22. PMID 36253957 DOI: 10.1080/17425247.2022.2134341 |
0.547 |
|
2022 |
Kumbham S, Ghosh A, Ghosh B, Biswas S. Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer. International Journal of Biological Macromolecules. PMID 36191788 DOI: 10.1016/j.ijbiomac.2022.09.250 |
0.557 |
|
2022 |
Ch S, Paul M, Ghosh B, Biswas S. Rebuttal, Replying to the "Letter to the Editor" entitled "Questionable micelle formation of the double hydrophilic block copolymer PEG-pHPMA". International Journal of Pharmaceutics. 122148. PMID 36130860 DOI: 10.1016/j.ijpharm.2022.122148 |
0.479 |
|
2022 |
Itoo AM, Vemula SL, Gupta MT, Giram MV, Kumar SA, Ghosh B, Biswas S. Multifunctional graphene oxide nanoparticles for drug delivery in cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 350: 26-59. PMID 35964787 DOI: 10.1016/j.jconrel.2022.08.011 |
0.531 |
|
2022 |
Vysyaraju NR, Paul M, Ch S, Ghosh B, Biswas S. Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumor-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer. Journal of Drug Targeting. 1-27. PMID 35723068 DOI: 10.1080/1061186X.2022.2092623 |
0.57 |
|
2022 |
Pulya S, Patel T, Paul M, Adhikari N, Banerjee S, Routholla G, Biswas S, Jha T, Ghosh B. Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer. European Journal of Medicinal Chemistry. 238: 114470. PMID 35635949 DOI: 10.1016/j.ejmech.2022.114470 |
0.511 |
|
2022 |
Itoo AM, Paul M, Ghosh B, Biswas S. Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer. Carbohydrate Polymers. 282: 119108. PMID 35123744 DOI: 10.1016/j.carbpol.2022.119108 |
0.512 |
|
2022 |
Kumbham S, Paul M, Itoo A, Ghosh B, Biswas S. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma. International Journal of Pharmaceutics. 614: 121479. PMID 35041911 DOI: 10.1016/j.ijpharm.2022.121479 |
0.545 |
|
2021 |
Routholla G, Pulya S, Patel T, Adhikari N, Abdul Amin S, Paul M, Bhagavatula S, Biswas S, Jha T, Ghosh B. Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model. Bioorganic Chemistry. 117: 105446. PMID 34717237 DOI: 10.1016/j.bioorg.2021.105446 |
0.511 |
|
2021 |
Ch S, Mishra P, Bhatt H, Ghosh B, Roy S, Biswas S. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis. Colloids and Surfaces. B, Biointerfaces. 208: 112113. PMID 34562784 DOI: 10.1016/j.colsurfb.2021.112113 |
0.557 |
|
2021 |
Bobde Y, Paul M, Patel T, Biswas S, Ghosh B. Polymeric micelles of a copolymer composed of all-trans retinoic acid, methoxy-poly(ethylene glycol), and b-poly(N-(2 hydroxypropyl) methacrylamide) as a doxorubicin-delivery platform and for combination chemotherapy in breast cancer. International Journal of Pharmaceutics. 120866. PMID 34237409 DOI: 10.1016/j.ijpharm.2021.120866 |
0.513 |
|
2021 |
Routholla G, Pulya S, Patel T, Abdul Amin S, Adhikari N, Biswas S, Jha T, Ghosh B. Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors. Bioorganic Chemistry. 114: 105050. PMID 34120025 DOI: 10.1016/j.bioorg.2021.105050 |
0.489 |
|
2021 |
Bobde Y, Patel T, Paul M, Biswas S, Ghosh B. PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer. Colloids and Surfaces. B, Biointerfaces. 204: 111833. PMID 34010799 DOI: 10.1016/j.colsurfb.2021.111833 |
0.569 |
|
2021 |
Ghosh B, Biswas S. Polymeric micelles in cancer therapy: State of the art. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33609621 DOI: 10.1016/j.jconrel.2021.02.016 |
0.569 |
|
2021 |
Pulya S, Mahale A, Bobde Y, Routholla G, Patel T, Swati, Biswas S, Sharma V, Kulkarni OP, Ghosh B. PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model. Acs Chemical Neuroscience. PMID 33577290 DOI: 10.1021/acschemneuro.0c00721 |
0.426 |
|
2020 |
Bhatt H, Ghosh B, Biswas S. Cell-Penetrating Peptide and α-Tocopherol-Conjugated Poly(amidoamine) Dendrimers for Improved Delivery and Anticancer Activity of Loaded Paclitaxel. Acs Applied Bio Materials. 3: 3157-3169. PMID 35025359 DOI: 10.1021/acsabm.0c00179 |
0.489 |
|
2020 |
Kumari P, Paul M, Bobde Y, Soniya K, Kiran Rompicharla SV, Ghosh B, Biswas S. Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment. Nanomedicine (London, England). PMID 33275041 DOI: 10.2217/nnm-2020-0232 |
0.552 |
|
2020 |
Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B. HDAC6 as privileged target in drug discovery: A perspective. Pharmacological Research. 105274. PMID 33171304 DOI: 10.1016/j.phrs.2020.105274 |
0.469 |
|
2020 |
Ghosh S, Lalani R, Maiti K, Banerjee S, Bhatt H, Bobde YS, Patel V, Biswas S, Bhowmick S, Misra A. Synergistic co-loading of vincristine improved chemotherapeutic potential of Pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. 102320. PMID 33075540 DOI: 10.1016/j.nano.2020.102320 |
0.329 |
|
2020 |
Kumari P, Paul M, Bhatt H, Rompicharla SVK, Sarkar D, Ghosh B, Biswas S. Chlorin e6 Conjugated Methoxy-Poly(Ethylene Glycol)-Poly(D,L-Lactide) Glutathione Sensitive Micelles for Photodynamic Therapy. Pharmaceutical Research. 37: 18. PMID 31897768 DOI: 10.1007/S11095-019-2750-0 |
0.581 |
|
2020 |
Bobde Y, Biswas S, Ghosh B. PEGylated N-(2 hydroxypropyl) methacrylamide-doxorubicin conjugate as pH-responsive polymeric nanoparticles for cancer therapy Reactive & Functional Polymers. 151: 104561. DOI: 10.1016/J.Reactfunctpolym.2020.104561 |
0.609 |
|
2020 |
Bobde Y, Biswas S, Ghosh B. Current trends in the development of HPMA-based block copolymeric nanoparticles for their application in drug delivery European Polymer Journal. 139: 110018. DOI: 10.1016/J.Eurpolymj.2020.110018 |
0.597 |
|
2019 |
Muddineti OS, Kiran Rompicharla SV, Kumari P, Bhatt H, Ghosh B, Biswas S. Lipid and poly (ethylene glycol)-conjugated Bi-functionalized Chlorine e6 micelles for NIR-Light Induced Photodynamic Therapy. Photodiagnosis and Photodynamic Therapy. 101633. PMID 31870896 DOI: 10.1016/J.Pdpdt.2019.101633 |
0.554 |
|
2019 |
Bhatt H, Kiran Rompicharla SV, Ghosh B, Torchilin V, Biswas S. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel. Nanomedicine (London, England). 14: 3159-3176. PMID 31855118 DOI: 10.2217/Nnm-2019-0128 |
0.608 |
|
2019 |
Kumari P, Kiran Rompicharla SV, Bhatt H, Ghosh B, Biswas S. Development of chlorin e6-conjugated poly(ethylene glycol)-poly(d,l-lactide) nanoparticles for photodynamic therapy. Nanomedicine (London, England). PMID 30874479 DOI: 10.2217/Nnm-2018-0255 |
0.582 |
|
2019 |
Bhatt H, Rompicharla SVK, Ghosh B, Biswas S. α-tocopherol succinate anchored PEGylated Poly(Amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in vitro and in-vivo therapeutic efficacy. Molecular Pharmaceutics. PMID 30817166 DOI: 10.1021/Acs.Molpharmaceut.8B01232 |
0.593 |
|
2019 |
Muddineti OS, Rompicharla SVK, Kumari P, Bhatt H, Ghosh B, Biswas S. Vitamin-E/lipid based PEGylated polymeric micellar doxorubicin to sensitize doxorubicin-resistant cells towards treatment Reactive and Functional Polymers. 134: 49-57. DOI: 10.1016/J.Reactfunctpolym.2018.10.012 |
0.632 |
|
2018 |
Vishnu Kiran Rompicharla S, Kumari P, Bhatt H, Ghosh B, Biswas S. Biotin Functionalized PEGylated Poly(Amidoamine) Dendrimer conjugate for Active Targeting of Paclitaxel in Cancer. International Journal of Pharmaceutics. PMID 30599231 DOI: 10.1016/J.Ijpharm.2018.12.069 |
0.603 |
|
2018 |
Rompicharla SVK, Trivedi P, Kumari P, Muddineti OS, Theegalapalli S, Ghosh B, Biswas S. Evaluation of Anti-Tumor Efficacy of Vorinostat Encapsulated Self-Assembled Polymeric Micelles in Solid Tumors. Aaps Pharmscitech. PMID 30132129 DOI: 10.1208/S12249-018-1149-2 |
0.612 |
|
2018 |
Muddineti OS, Shah A, Rompicharla SVK, Ghosh B, Biswas S. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells. International Journal of Biological Macromolecules. PMID 29953893 DOI: 10.1016/J.Ijbiomac.2018.06.114 |
0.619 |
|
2018 |
Rompicharla SVK, Kumari P, Ghosh B, Biswas S. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer. Artificial Cells, Nanomedicine, and Biotechnology. 1-13. PMID 29790795 DOI: 10.1080/21691401.2018.1470527 |
0.602 |
|
2018 |
Kumari P, Rompicharla SVK, Muddineti OS, Ghosh B, Biswas S. Transferrin-anchored poly(lactide) micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids. International Journal of Biological Macromolecules. PMID 29753013 DOI: 10.1016/J.Ijbiomac.2018.05.040 |
0.645 |
|
2018 |
Bhatt H, Rompicharla SVK, Komanduri N, Shah A, Paradkar S, Ghosh B, Biswas S. Development of curcumin-loaded solid lipid nanoparticles utilizing glyceryl monostearate as single lipid using QbD approach: Characterization and Evaluation of anticancer activity against human breast cancer cell line. Current Drug Delivery. PMID 29732970 DOI: 10.2174/1567201815666180503120113 |
0.593 |
|
2018 |
Muddineti OS, Kumari P, Ghosh B, Biswas S. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin. Pharmaceutical Research. 35: 97. PMID 29541866 DOI: 10.1007/S11095-018-2382-9 |
0.551 |
|
2018 |
Deshpande P, Jhaveri A, Pattni B, Biswas S, Torchilin V. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Drug Delivery. 25: 517-532. PMID 29433357 DOI: 10.1080/10717544.2018.1435747 |
0.421 |
|
2018 |
Muddineti OS, Vanaparthi A, Rompicharla SVK, Kumari P, Ghosh B, Biswas S. Cholesterol and vitamin E-conjugated PEGylated polymeric micelles for efficient delivery and enhanced anticancer activity of curcumin: evaluation in 2D monolayers and 3D spheroids. Artificial Cells, Nanomedicine, and Biotechnology. 1-14. PMID 29426248 DOI: 10.1080/21691401.2018.1435551 |
0.628 |
|
2017 |
Kumari P, Jain S, Ghosh B, Zorin VP, Biswas S. Polylactide-based block co-polymeric micelles loaded with Chlorin e6 for Photodynamic Therapy: In vitro evaluation in Monolayer and 3D spheroid models. Molecular Pharmaceutics. PMID 28969421 DOI: 10.1021/Acs.Molpharmaceut.7B00548 |
0.626 |
|
2017 |
Kiran SV, Himanshu B, Shah A, Komanduri N, Vijayasarathy D, Ghosh B, Biswas S. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of Curcumin loaded solid lipid nanoparticles for improved anticancer activity. Chemistry and Physics of Lipids. PMID 28842128 DOI: 10.1016/J.Chemphyslip.2017.08.009 |
0.615 |
|
2017 |
Muddineti OS, Kumari P, Ray E, Ghosh B, Biswas S. Curcumin-loaded chitosan-cholesterol micelles: evaluation in monolayers and 3D cancer spheroid model. Nanomedicine (London, England). PMID 28573926 DOI: 10.2217/Nnm-2017-0036 |
0.598 |
|
2017 |
Muddineti OS, Kumari P, Ghosh B, Torchilin VP, Biswas S. d-α-Tocopheryl Succinate/Phosphatidyl Ethanolamine Conjugated Amphiphilic Polymer-Based Nanomicellar System for the Efficient Delivery of Curcumin and To Overcome Multiple Drug Resistance in Cancer. Acs Applied Materials & Interfaces. PMID 28504884 DOI: 10.1021/Acsami.7B01087 |
0.627 |
|
2017 |
Kumari P, Muddineti OS, Rompicharla SV, Ghanta P, B B N AK, Ghosh B, Biswas S. Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy. Drug Delivery. 24: 209-223. PMID 28156164 DOI: 10.1080/10717544.2016.1245365 |
0.584 |
|
2016 |
Kiran Rompicharla SV, Trivedi P, Kumari P, Ghanta P, Ghosh B, Biswas S. Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo. Nanomedicine (London, England). PMID 27879153 DOI: 10.2217/Nnm-2016-0321 |
0.577 |
|
2016 |
Muddineti OS, Ghosh B, Biswas S. Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery. Expert Opinion On Drug Delivery. PMID 27560621 DOI: 10.1080/17425247.2016.1229300 |
0.602 |
|
2016 |
Muddineti OS, Kumari P, Ajjarapu S, Lakhani PM, Bahl R, Ghosh B, Biswas S. Xanthan gum stabilized PEGylated gold nanoparticles for improved delivery of curcumin in cancer. Nanotechnology. 27: 325101. PMID 27348749 DOI: 10.1088/0957-4484/27/32/325101 |
0.594 |
|
2016 |
Kumari P, Swami MO, Lakhani PM, Nadipalli SK, Myneni S, Ghosh B, Biswas S. Erratum to: Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study. Pharmaceutical Research. PMID 27080101 DOI: 10.1007/S11095-016-1925-1 |
0.596 |
|
2016 |
Perche F, Biswas S, Patel NR, Torchilin VP. Hypoxia-Responsive Copolymer for siRNA Delivery. Methods in Molecular Biology (Clifton, N.J.). 1372: 139-62. PMID 26530922 DOI: 10.1007/978-1-4939-3148-4_12 |
0.37 |
|
2015 |
Biswas S, Kumari P, Lakhani PM, Ghosh B. Recent advances in polymeric micelles for anti-cancer drug delivery. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 26747018 DOI: 10.1016/J.Ejps.2015.12.031 |
0.61 |
|
2015 |
Kumari P, Swami MO, Nadipalli SK, Myneni S, Ghosh B, Biswas S. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study. Pharmaceutical Research. PMID 26597940 DOI: 10.1007/S11095-015-1830-Z |
0.603 |
|
2015 |
Lakhani PM, Rompicharla SV, Ghosh B, Biswas S. An overview of synthetic strategies and current applications of gold nanorods in cancer treatment. Nanotechnology. 26: 432001. PMID 26446935 DOI: 10.1088/0957-4484/26/43/432001 |
0.542 |
|
2015 |
Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. Journal of Drug Targeting. 1-13. PMID 26061298 DOI: 10.3109/1061186X.2015.1051049 |
0.604 |
|
2015 |
Biswas S, Dutta A, Dolai M, Bhowmick I, Rouzières M, Clérac R, Panja A, Ali M. Novel Cu(II)-M(II)-Cu(II) (M = Cu or Ni) trinuclear and [NaCu] hexanuclear complexes assembled by bi-compartmental ligands: syntheses, structures, magnetic and catalytic studies. Dalton Transactions (Cambridge, England : 2003). 44: 9426-38. PMID 25915730 DOI: 10.1039/C4Dt03728F |
0.373 |
|
2015 |
Muddineti OS, Ghosh B, Biswas S. Current trends in using polymer coated gold nanoparticles for cancer therapy. International Journal of Pharmaceutics. 484: 252-67. PMID 25701627 DOI: 10.1016/J.Ijpharm.2015.02.038 |
0.597 |
|
2014 |
Perche F, Biswas S, Wang T, Zhu L, Torchilin VP. Hypoxia-targeted siRNA delivery. Angewandte Chemie (International Ed. in English). 53: 3362-6. PMID 24554550 DOI: 10.1002/Anie.201308368 |
0.347 |
|
2014 |
Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Advanced Drug Delivery Reviews. 66: 26-41. PMID 24270008 DOI: 10.1016/J.Addr.2013.11.004 |
0.425 |
|
2014 |
Navarro G, Essex S, Sawant RR, Biswas S, Nagesha D, Sridhar S, de ILarduya CT, Torchilin VP. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 411-9. PMID 23928214 DOI: 10.1016/J.Nano.2013.07.016 |
0.32 |
|
2014 |
Kozlowska D, Biswas S, Fox EK, Wu B, Bolster F, Edupuganti OP, Torchilin V, Eustace S, Botta M, O'Kennedy R, Brougham DF. Gadolinium-loaded polychelating amphiphilic polymer as an enhanced MRI contrast agent for human multiple myeloma and non Hodgkin's lymphoma (human Burkitt's lymphoma) Rsc Advances. 4: 18007. DOI: 10.1039/C3Ra45400B |
0.314 |
|
2013 |
Biswas S, Torchilin VP. Dendrimers for siRNA Delivery. Pharmaceuticals (Basel, Switzerland). 6: 161-83. PMID 24275946 DOI: 10.3390/Ph6020161 |
0.351 |
|
2013 |
Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (London, England). 8: 1509-28. PMID 23914966 DOI: 10.2217/Nnm.13.118 |
0.391 |
|
2013 |
Biswas S, Dutta A, Debnath M, Dolai M, Das KK, Ali M. A novel thermally stable hydroperoxo-copper(II) complex in a Cu(N2O2) chromophore of a potential N4O2 donor Schiff base ligand: synthesis, structure and catalytic studies. Dalton Transactions (Cambridge, England : 2003). 42: 13210-9. PMID 23884097 DOI: 10.1039/c3dt51359a |
0.396 |
|
2013 |
Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP. Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. Cancer Letters. 335: 191-200. PMID 23419527 DOI: 10.1016/J.Canlet.2013.02.020 |
0.328 |
|
2013 |
Biswas S, Dodwadkar NS, Deshpande PP, Parab S, Torchilin VP. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 84: 517-25. PMID 23333899 DOI: 10.1016/J.Ejpb.2012.12.021 |
0.343 |
|
2013 |
Biswas S, Deshpande PP, Navarro G, Dodwadkar NS, Torchilin VP. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery. Biomaterials. 34: 1289-301. PMID 23137395 DOI: 10.1016/J.Biomaterials.2012.10.024 |
0.401 |
|
2012 |
Gogoi S, Biswas S, Modi G, Antonio T, Reith ME, Dutta AK. Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potency. Acs Medicinal Chemistry Letters. 3: 991-996. PMID 23275802 DOI: 10.1021/Ml3002117 |
0.727 |
|
2012 |
Biswas S, Dodwadkar NS, Piroyan A, Torchilin VP. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials. 33: 4773-82. PMID 22469294 DOI: 10.1016/J.Biomaterials.2012.03.032 |
0.385 |
|
2012 |
Sawant RR, Sriraman SK, Navarro G, Biswas S, Dalvi RA, Torchilin VP. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials. 33: 3942-51. PMID 22365809 DOI: 10.1016/J.Biomaterials.2011.11.088 |
0.346 |
|
2012 |
Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 159: 393-402. PMID 22286008 DOI: 10.1016/J.Jconrel.2012.01.009 |
0.399 |
|
2012 |
Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (London, England). 7: 65-78. PMID 22191778 DOI: 10.2217/Nnm.11.93 |
0.337 |
|
2011 |
Biswas S, Dodwadkar NS, Sawant RR, Torchilin VP. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjugate Chemistry. 22: 2005-13. PMID 21870873 DOI: 10.1021/Bc2002133 |
0.344 |
|
2011 |
Biswas S, Dodwadkar NS, Sawant RR, Koshkaryev A, Torchilin VP. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. Journal of Drug Targeting. 19: 552-61. PMID 21348804 DOI: 10.3109/1061186X.2010.536983 |
0.396 |
|
2010 |
Ghosh SK, Bandyopadhyay D, Ghosh A, Dutta A, Biswas S, Mandal RK, Jamadar NS. Mucocutaneous features of hand, foot, and mouth disease: a reappraisal from an outbreak in the city of Kolkata. Indian Journal of Dermatology, Venereology and Leprology. 76: 564-6. PMID 20827002 DOI: 10.4103/0378-6323.69042 |
0.352 |
|
2010 |
Li C, Biswas S, Li X, Dutta AK, Le W. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin. Journal of Neuroscience Research. 88: 2513-23. PMID 20623619 DOI: 10.1002/Jnr.22405 |
0.513 |
|
2010 |
Schmitt KC, Mamidyala S, Biswas S, Dutta AK, Reith ME. Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter. Journal of Neurochemistry. 112: 1605-18. PMID 20067583 DOI: 10.1111/J.1471-4159.2010.06583.X |
0.42 |
|
2009 |
Brown DA, Mishra M, Zhang S, Biswas S, Parrington I, Antonio T, Reith ME, Dutta AK. Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptor. Bioorganic & Medicinal Chemistry. 17: 3923-33. PMID 19427222 DOI: 10.1016/J.Bmc.2009.04.031 |
0.529 |
|
2008 |
Dutta AK, Ghosh B, Biswas S, Reith ME. D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action. European Journal of Pharmacology. 589: 73-9. PMID 18561912 DOI: 10.1016/J.Ejphar.2008.05.008 |
0.625 |
|
2008 |
Biswas S, Hazeldine S, Ghosh B, Parrington I, Kuzhikandathil E, Reith ME, Dutta AK. Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity. Journal of Medicinal Chemistry. 51: 3005-19. PMID 18410082 DOI: 10.1021/Jm701524H |
0.643 |
|
2008 |
Biswas S, Zhang S, Fernandez F, Ghosh B, Zhen J, Kuzhikandathil E, Reith ME, Dutta AK. Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action. Journal of Medicinal Chemistry. 51: 101-17. PMID 18072730 DOI: 10.1021/Jm070860R |
0.641 |
|
2005 |
Biswas S, Bhattacharyya J, Dutta AG. Oxidant induced injury of erythrocyte-role of green tea leaf and ascorbic acid. Molecular and Cellular Biochemistry. 276: 205-10. PMID 16132702 DOI: 10.1007/s11010-005-4062-4 |
0.396 |
|
Show low-probability matches. |